scispace - formally typeset
N

Neil Mann

Researcher at RMIT University

Publications -  72
Citations -  8731

Neil Mann is an academic researcher from RMIT University. The author has contributed to research in topics: Polyunsaturated fatty acid & Eicosapentaenoic acid. The author has an hindex of 38, co-authored 69 publications receiving 8068 citations. Previous affiliations of Neil Mann include Emory University & Deakin University.

Papers
More filters
Journal ArticleDOI

Origins and evolution of the Western diet: health implications for the 21st century

TL;DR: The evolutionary collision of the authors' ancient genome with the nutritional qualities of recently introduced foods may underlie many of the chronic diseases of Western civilization.
Journal ArticleDOI

Plant-animal subsistence ratios and macronutrient energy estimations in worldwide hunter-gatherer diets

TL;DR: This analysis showed that whenever and wherever it was ecologically possible, hunter-gatherers consumed high amounts (45-65% of energy) of animal food, which produces universally characteristic macronutrient consumption ratios in which protein is elevated at the expense of carbohydrates.
Journal ArticleDOI

Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids.

TL;DR: The results indicate that the majority of Australians are failing to meet intake recommendations for LC n−3 PUFA (>0.2 g per day) and emphasize the need for strategies, to increase the availability and consumption of n−2-containing foods.
Journal ArticleDOI

Dietary flavanols and procyanidin oligomers from cocoa (Theobroma cacao) inhibit platelet function

TL;DR: Cocoa flavanol and procyanidin supplementation for 28 d significantly increased plasma epicatechin and catechin concentrations and significantly decreased platelet function, which support the results of acute studies that used higher doses of cocoa flavanols and proCyanidins.
Journal ArticleDOI

Efficacy and Safety of a Chinese Herbal Medicine Formula (RCM-104) in the Management of Simple Obesity: A Randomized, Placebo-Controlled Clinical Trial

TL;DR: RCM-104 treatment appears to be well tolerated and beneficial in reducing BW and BMI in obese subjects, and eleven items of the WLQOQ were significantly improved in the RCM- 104 group while only 2 items were significantlyImproved in the placebo group.